Location: Madrid
Synced from ClinicalTrials.gov · August 07, 2026
Clinical studies recruiting near Madrid
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN) Phase 2 · Research Site · Alexion Pharmaceuticals, Inc. · NCT07157787 A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav Phase 3 · Hospital Universitario La Princesa · Pfizer · NCT05020236 A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra Phase 2 · Hospital Universitario La Paz · AbbVie · NCT06602479 A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adult Phase 1 · Hospital Universitario La paz · Antonio Pérez Martínez · NCT06087341 KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used W Phase 1/Phase 2 · Hospital Universitario Quiron Madrid ( Site 0091) · Merck Sharp & Dohme LLC · NCT04165070 Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Tre Phase 2 · Spanish Cooperative Group for Gastrointestinal Tumour Therap · Spanish Cooperative Group for the Treatment of Digestive Tum · NCT06207656 Observational Study Protocol: LIVER-R Phase N/A · Research Site · AstraZeneca · NCT06252753 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract Phase 3 · Hospital La Princesa · Eli Lilly and Company · NCT07218380 Impact of Virtual Reality Physiotherapy on Multiple Sclerosis Patients NA · Fundación Esclerosis Multiple Madrid (FEMM) · European University of Madrid · NCT06735053 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Phase 3 · CON-38002, Madrid, Madrid · Colorado Prevention Center · NCT06024746 Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN Phase 3 · Novartis Investigative Site · Novartis Pharmaceuticals · NCT05755386 Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure NA · Hospital Universitario La Paz · University Hospital, Geneva · NCT06207383 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W Phase 3 · Hospital Universitario Ramón y Cajal · Pfizer · NCT07028853 Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease Phase 3 · Hospital Universitario Ramon y Cajal · Amgen · NCT04528082 A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer Phase 1 · Hosp. Univ. 12 de Octubre · Johnson & Johnson Enterprise Innovation Inc. · NCT06116786 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer Phase 3 · Hospital Universitario Ramon y Cajal · Daiichi Sankyo · NCT07022483 Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Phase 3 · La Paz University Hospital · CSL Behring · NCT07080905 A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients Wit Phase 1 · Hospital Universitario 12 De Octubre · eleva GmbH · NCT07483827 Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia Phase 3 · Hospital Infantil Universitario Nino Jesus · Princess Maxima Center for Pediatric Oncology · NCT05327894 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line Phase 3 · Merck Sharp & Dohme LLC · NCT06136559 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Phase 2/Phase 3 · Hospital Universitario Ramón y Cajal · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) Phase 3 · Hospital Universitario Ramón y Cajal-Medical Oncology ( Site · Merck Sharp & Dohme LLC · NCT06393374 Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors. Phase N/A · Hospital General Universitario Gregorio Marañon · Spanish Oncology Genito-Urinary Group · NCT06724159 A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) Phase 2/Phase 3 · Hospital Universitario La Paz ( Site 3404) · Merck Sharp & Dohme LLC · NCT07266831 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in Phase 3 · Hospital Universitario 12 de Octubre · Pfizer · NCT06758401 Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients Phase 2 · Hospital Clínico San Carlos (HCSC) · Miltenyi Biomedicine GmbH · NCT04844866 A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease Phase 3 · Site SP34001 · Astellas Pharma Global Development, Inc. · NCT05970172 A Study of More Frequent Dosing of VCN-01 Combined With Standard Chemotherapy in Patients With Newly Diagnosed Metastati Phase 1/Phase 2 · Hospital 12 de Octubre · Theriva Biologics SL · NCT07701486 Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients NA · Mucosa Innovations S.L. · Mucosa Innovations, S.L. · NCT05635929 Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1) Phase 1 · Centro Integral Oncologici Clara Campal · Ichnos Sciences SA · NCT05862012
Look up another city
Look up another condition